BACKGROUND: Mucosal alterations after Roux-en-Y gastric bypass for morbid obesity have not been clearly evaluated. This study aims to analyze the mucosal alterations (proliferative status (Ki-67); apoptosis (caspase-3 and BCL-2); hormonal function (gastrin)) in the excluded stomach. METHODS: Double-balloon enteroscopy was performed in 35 patients who underwent Roux-en-Y gastric bypass longer than 36 months. Multiple biopsies of the proximal pouch and the excluded gastric mucosa were collected. Gastric biopsies from 32 non-operated obese patients were utilized as controls. Endoscopic biopsies were cut from tissue blocks fixed in formalin and embedded in paraffin. Sections 4 μm thick were examined for immunoexpression using the streptavidin-biotin-peroxidase method. RESULTS: The two groups were comparable for age, gender, gastritis, intestinal metaplasia, and Helicobacter pylori. The mean number of positive gastrin cells was 55.5 (standard deviation (SD) = 11.7) in the control group and 29.6 (SD = 7.9) in the cases, p = 0.0003. Ki-67 proliferative index in cases (body = 24.7%, antrum = 24.9%) was significantly higher compared to controls (body = 15.0% and antrum = 17.7%), p = 0.002 and 0.01, respectively. Caspase-3 immunoexpression was higher in the controls compared to the excluded stomach (46 vs. 31%), p = 0.02. There was no statistical difference between CD3, CD8, and Bcl-2 immunoexpressions in the control and cases. CONCLUSIONS: Cell proliferation is increased and apoptosis is downregulated in the excluded gastric mucosa compared to the non-operated obese controls. Alterations in cell turnover and in hormonal secretions in these conditions may be of relevance in long-term follow-up.
BACKGROUND:Mucosal alterations after Roux-en-Y gastric bypass for morbid obesity have not been clearly evaluated. This study aims to analyze the mucosal alterations (proliferative status (Ki-67); apoptosis (caspase-3 and BCL-2); hormonal function (gastrin)) in the excluded stomach. METHODS: Double-balloon enteroscopy was performed in 35 patients who underwent Roux-en-Y gastric bypass longer than 36 months. Multiple biopsies of the proximal pouch and the excluded gastric mucosa were collected. Gastric biopsies from 32 non-operated obesepatients were utilized as controls. Endoscopic biopsies were cut from tissue blocks fixed in formalin and embedded in paraffin. Sections 4 μm thick were examined for immunoexpression using the streptavidin-biotin-peroxidase method. RESULTS: The two groups were comparable for age, gender, gastritis, intestinal metaplasia, and Helicobacter pylori. The mean number of positive gastrin cells was 55.5 (standard deviation (SD) = 11.7) in the control group and 29.6 (SD = 7.9) in the cases, p = 0.0003. Ki-67 proliferative index in cases (body = 24.7%, antrum = 24.9%) was significantly higher compared to controls (body = 15.0% and antrum = 17.7%), p = 0.002 and 0.01, respectively. Caspase-3 immunoexpression was higher in the controls compared to the excluded stomach (46 vs. 31%), p = 0.02. There was no statistical difference between CD3, CD8, and Bcl-2 immunoexpressions in the control and cases. CONCLUSIONS: Cell proliferation is increased and apoptosis is downregulated in the excluded gastric mucosa compared to the non-operated obese controls. Alterations in cell turnover and in hormonal secretions in these conditions may be of relevance in long-term follow-up.
Authors: Deborah A Corsini; Celso A M Simoneti; Gisele Moreira; Sizenando E Lima; Arthur B Garrido Journal: Obes Surg Date: 2006-07 Impact factor: 4.129
Authors: Robson K Ishida; Joel Faintuch; Ana M R Paula; Christiane A Risttori; Sabrina N Silva; Elaine S Gomes; Rejane Mattar; Rogerio Kuga; Adriana S Ribeiro; Paulo Sakai; Hermes V Barbeiro; Denise F Barbeiro; Francisco G Soriano; Ivan Cecconello Journal: Obes Surg Date: 2007-06 Impact factor: 4.129
Authors: P Sakai; R Kuga; A V Safatle-Ribeiro; J Faintuch; J J Gama-Rodrigues; R K Ishida; C K Furuya; H Yamamoto; S Ishioka Journal: Endoscopy Date: 2005-06 Impact factor: 10.093
Authors: Attila Csendes; Patricio Burdiles; Karin Papapietro; Juan Carlos Diaz; Fernando Maluenda; Ana Burgos; Jorge Rojas Journal: J Gastrointest Surg Date: 2005-01 Impact factor: 3.452
Authors: Rogerio Kuga; Adriana V Safatle-Ribeiro; Joel Faintuch; Robson K Ishida; Carlos K Furuya; Arthur B Garrido; Ivan Cecconello; Shinichi Ishioka; Paulo Sakai Journal: Arch Surg Date: 2007-10
Authors: Renata V A Collares-Pelizaro; José S Santos; Carla B Nonino; Larissa Alves dos Reis Dias; Cristiane M Gaitani; Wilson Salgado Journal: Obes Surg Date: 2017-09 Impact factor: 4.129
Authors: Konstantinos Arapis; Jean Baptiste Cavin; Laura Gillard; Françoise Cluzeaud; Philippe Lettéron; Robert Ducroc; Johanne Le Beyec; Muriel Hourseau; Anne Couvelard; Jean-Pierre Marmuse; Maude Le Gall; André Bado Journal: PLoS One Date: 2015-03-30 Impact factor: 3.240
Authors: Thomas C C Boerlage; Floris Westerink; Dennis C W Poland; Inge L Huibregtse; Yair I Z Acherman; Victor E A Gerdes Journal: Obes Surg Date: 2016-12 Impact factor: 4.129
Authors: Nikkie van der Wielen; Givan Paulus; Mark van Avesaat; Ad Masclee; Jocelijn Meijerink; Nicole Bouvy Journal: Obes Surg Date: 2017-03 Impact factor: 4.129
Authors: Zachary R Eagle; Francis Essien; Kimberly Zibert; Charles Miller; Melissa Van Dellen; Rina Eden; Ross Pinson Journal: Clin Case Rep Date: 2022-01-23